Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
100%
Lung Neoplasms
59%
Neoplasms
48%
ErbB Receptors
36%
Mutation
30%
Adenocarcinoma of Lung
30%
Erlotinib Hydrochloride
25%
Survival
24%
Biomarkers
20%
Thyroid Nuclear Factor 1
19%
Squamous Cell Carcinoma
19%
Neoplasm Metastasis
18%
Lung
17%
Death-Associated Protein Kinases
17%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
17%
Dasatinib
16%
Adenocarcinoma
15%
Cyclooxygenase 2
15%
Protein-Tyrosine Kinases
14%
Colonic Neoplasms
14%
Oncogenes
13%
Therapeutics
12%
Progression-Free Survival
12%
erbB-1 Genes
12%
Ligands
12%
Genes
11%
Thymoma
11%
Epithelial-Mesenchymal Transition
11%
Tongue Neoplasms
10%
Phosphatidylinositol 3-Kinase
10%
Cell Line
9%
Apoptosis
9%
Sorafenib
9%
Gene Dosage
9%
Proteins
9%
Methylation
9%
Epithelium
8%
Thymus Neoplasms
8%
Interleukin-6
8%
Colorectal Neoplasms
7%
Adjuvant Chemotherapy
7%
Tumor Microenvironment
7%
PAX8 Transcription Factor
7%
Carcinogenesis
7%
Chemoprevention
7%
Interleukin-10
7%
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
7%
Squamous Cell Carcinoma of Head and Neck
7%
PLX 4720
7%
Neuroendocrine Carcinoma
7%